Introduction: Pneumonia is the most common cause of mortality and morbidity in children in underdeveloped countries. e common bacterial agents are Streptococcus pneumonia followed by Haemophilus in uenzae type b. e only measure to treat bacterial pneumonia is the correct use of antibiotics along with oxygen in moderate to severe cases. e objectives of this study were to see the clinical features of community-acquired pneumonia and to observe the response to treatment with crystalline penicillin in hospitalized children. Methods: is study was a prospective study. e children aged between two months to 59 months with pneumonia were treated with intravenous crystalline penicillin. Response was observed by normalization of respiratory rate and absence of lower chest indrawing. Results: Out of 88 children treated, 79(89.8%) showed improvement in 48 hours. In children who had tachypnoea, 62.9% showed normalization in respiratory rate in the rst 24 hours and 37.1 percent in 48 hours of treatment. Similarly, among children with lower chest indrawing; 61.1% showed improvement in 24 hours and the remaining in 48 hours. In 24 hours of treatment 17.7% of children became afebrile and 46.8% in 48hours of treatment. Conclusion: e most common clinical features like cough, fever, tachypnoea and lower chest indrawing can be used to diagnose CAP where chest X-ray is not possible. e response to treatment with crystalline penicillin is very good and, thus, can be used as the rst line drug in the treatment of children with CAP.
INTRODUCTION
Community-acquired pneumonia (CAP) is de ned as an acute infection of the pulmonary parenchyma in a patient who has acquired the infection in the community 1 . It is caused by a number of infectious agents, including viruses, bacteria and fungi. e most common bacteria in causing pneumonia in children are Streptococcus pneumoniae followed by Haemophilus in uenzae type b (Hib) 2, 3 . CAP is the most common cause of childhood deaths in the developing countries 4 . In the developed countries the burden of the disease is in order of 10-15 cases/1000 children per year and a hospital admission rate of 1-4/1000 per year 5 . Use of antibiotics is one of the main strategies used to overcome children's morbidity and mortality in such circumstances 6 . World Health Organization (WHO) has recommended penicillin G to children hospitalized with severe CAP in developing countries 7, 8 . e rational for such a choice is, to treat Streptococcus Pneumonia, which is the most common cause of bacterial CAP who are appropriately treated could be seen clinically within 24 to 48 hours 9 . Penicillin resistant strains of streptococcus pneumonie is emerging worldwide 10, 11 . Intermediate or high-level resistance to penicillin has become a signi cant problem. Children, particularly those living in child care facilities and those receiving frequent courses of antibiotics, appear to be important carriers of resistant strains 12 . us the objective of this study was to observe the clinical response of the children hospitalized with communityacquired pneumonia to the treatment with crystalline penicillin and to see the clinical features of communityacquired pneumonia in hospitalized children. 10 and children with chest X-ray ndings suggestive of pneumonia were included in this study.
METHODS

Crystalline Penicillin for Community
Among the enrolled children the respiratory rate and chest indrawing were observed when the children were calm and quiet. Besides, Oxygen saturation (SpO 2 ) was monitored using pulse oximeter with a nger probe. e respiratory rate was counted twice if it was equal or above the reference range for each age group. e second count was recorded as the RR for the child.
e RR count was done by experienced paediatrician. Hypoxemia was de ned as oxygen saturation less than 90% in room air 10 . Pneumonia was con rmed if a pulmonary in ltrate or pleural e usion was described by a quali ed radiologist.
Fever was treated with paracetamol as and when required and hypoxemia if present was treated with oxygen via nasal cannula. ose children that quali ed the above criteria were hospitalized and treated with intravenous crystalline penicillin (CP) @200,000 IU/kg/day in four divided doses a er the skin sensitivity test. Axillary temperature, respiratory rate, chest indrawing and oxygen saturation of the enrolled children were recorded 6 hourly. e response was measured by normalization of respiratory rate and absence of chest indrawing at 24 hours and 48 hours of treatment. If no improvement were seen in 48 hours of intravenous CP, the child were treated with other antibiotics as per the hospital protocol. Improvement in signs and symptoms were considered "improved" only at 24 hour and 48 hours of initiation of treatment to allow adequate time for action of antibiotics.
Children with underlying debilitating or chronic pulmonary illnesses and heart disease, children already taking oral antibiotics at the time of enrollment, those who are known allergic to penicillin group of drugs, patients requiring referrals to other centers for various reasons and children without evidence of pneumonia on chest X-Ray were excluded from this study.
RESULTS
A total of 200 children were screened and 88 children who met the inclusion criteria were enrolled in the study. Among the enrolled patients 55.68% were males. e mean age of children was 33.26 in the age group of 2-59 months.
ere were 14(15.9%) children within the age group 2-12 months and 74(84.1%) children aged more than 12-59 months. 
Table1. Showing improvement in signs and
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All of the three (3.34%) children presenting with hypoxia at the time of enrollment maintained their Sp02 above 90% at room air in the rst 24 hours of treatment with intravenous CP. Among children who presented with fever, 17.7% became afebrile in 24 hours and 46.8% became afebrile in 48 hours of treatment and a er that there was no need of Paracetamol in them. Out of 83(94%) children presenting with cough, the mother reported decrease in cough only in 6% of children in 24 hours and 21.7% in 48 hours of treatment.
All the enrolled case recovered completely. Out of 9 cases who didn't respond to CP , two developed pleural e usion, one empyema thoracic and six remained tachypnoeic with chest indrawing even a er 48 hours of CP.
DISCUSSION
e estimated incidences of pneumonia in India, Pakistan and Bangladesh are 44 million, 7 million and 6 million repectively 2 . e demographic and health survey done in Nepal in 2011 showed that 5% of the children less than ve years of age had symptoms of acute respiratory illness (ARI), 19% had fever and 14% had diarrhea 2 weeks preceding the survey. ARI and severe diarrhoea causing dehydration are the major causes of childhood mortality in Nepal 3 . But the published data of death due to pneumonia in children less than ve years of age is lacking.
In our study the main presenting clinical feature of pneumonia was cough (94%) followed by fever, tachypnoea and tachypnoea with lower chest indrawing. e least common feature was hypoxia. is is supported by a similar study done in Himachal Pradesh, India where the most common presenting complaints were fever and cough followed by rapid or di culty in breathing. 13 Similarly a study done in children >1 year of age with the rst episode of wheezing found that the combination of tachypnea, tachycardia, fever, and localized ndings (rales or wheezing) both before and a er bronchodilator therapy could identify 95% of patients with pneumonia.
14 Another study done in 154 hospitalized children aged more than two months with CAP showed that the most common presenting complaints of pneumonia were cough (99.2%), fever (97.2%) and di culty in breathing (56.5%). e ndings were tachypnea (75.2%), fever (49.7%) and crackles (33.8%). 15 All these show that fever, cough and tachypnoea can be used as the diagnostic tool for pneumonia where chest X-ray is not always possible especially in rural and under equipped health settings.
Since most of the causative agents of childhood pneumonia cannot be detected, antibiotic treatment is most o en empiric, especially in underdeveloped countries. Various antibiotics are being used in the treatment protocol of CAP worldwide 16 and so also in Nepal. In our study the data showed that CP successfully treated the great majority (89.8%) of the children aged between 2 to 59 months with radiographically con rmed CAP.
ese results are also similar to the result shown in the retrospective cohort study done in hospitalized children with CAP in Brazil where Penicillin G successfully treated 82% (126/154) of the study group and the improvement was markedly seen on the rst day of treatment itself. 15 Another study done in Finland showed that out of 153 children hospitalized for uncomplicated CAP, 66% were treated with penicillin G and they also showed a rapid and uneventful recovery. 17 Penicillin G is still considered a drug of choice in hospitalized children with CAP even in many European countries with low penicillin resistance of pneumococci. 18, 19, 20 Penicillin G is no longer recommended in the United States as the rst- choice drug because of limited supply and the increasing resistance of pneumococci to penicillin 21 , whereas in western countries like Finland, 95% of pneumococcal strains still remained sensitive to penicillin. 22 Since a majority of children with CAP responded signi cantly well to CP in our study, it could still be considered a drug of choice in hospitalized children with CAP in low income and resource poor countries like Nepal.
Since the aim of the study was to see the response to treatment with antibiotics (CP) in diagnosed cases of pneumonia, the onset of symptoms of ARI, days of hospital admission, nutritional status and other confounding variables were not included in this study. is was a descriptive study in which a cohort of children was followed up. erefore, further statistical analysis was not considered of additional value. e relatively small sample size was also one of the limitations of this study.
CONCLUSIONS
Crystalline Penicillin is a very good drug for the treatment of CAP and can still be used as the rst drug in the treatment of children with CAP. e most common clinical features like cough, fever, tachypnoea and lower chest indrawing can still be used in the diagnosis of CAP where chest Xray facilities are absent. is study however had certain limitations like; absence of bacteriological diagnosis and a relatively small sample size.
